CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,690 | +5.2% | 250,000 | 0.0% | 0.08% | -45.4% |
| Q1 2023 | $2,558 | -3.0% | 250,000 | 0.0% | 0.15% | +3.4% |
| Q4 2022 | $2,638 | -99.9% | 250,000 | 0.0% | 0.15% | +7.3% |
| Q3 2022 | $3,205,000 | 0.0% | 250,000 | 0.0% | 0.14% | -19.9% |
| Q2 2022 | $3,205,000 | +22.4% | 250,000 | 0.0% | 0.17% | +55.5% |
| Q1 2022 | $2,618,000 | -32.1% | 250,000 | 0.0% | 0.11% | +4.8% |
| Q4 2021 | $3,858,000 | +70.9% | 250,000 | +150.0% | 0.10% | +110.0% |
| Q3 2021 | $2,257,000 | -12.3% | 100,000 | 0.0% | 0.05% | -3.8% |
| Q2 2021 | $2,575,000 | -38.2% | 100,000 | 0.0% | 0.05% | -29.7% |
| Q1 2021 | $4,167,000 | – | 100,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |